A single dose of an experimental jab has been found to cut “bad” cholesterol levels by half within six months of treatment in ...

A new FDA-approved daily pill aimed at lowering “bad” cholesterol is drawing attention from doctors and patients looking for ...

Heart disease remains the leading cause of death in the United States, but the latest 2026 cholesterol management guidelines emphasize that prevention begins much earlier than many people realize.

For high cholesterol, bacon and sausage aren't created equal. A dietitian explains saturated fat, sodium, serving size, and the better breakfast choice.

Clinical trials in the US and China reveal a groundbreaking nanodrug injection that could potentially control bad cholesterol ...

Shares of Novartis fell more than 3% on Monday after its cholesterol drug failed in a closely watched study, dealing ‌a blow ...

Novartis’ failure raises the stakes for Amgen and Eli Lilly in the race to turn lower Lp(a) levels into fewer heart attacks ...

The silent risk of bad cholesterol and heart disease threatens the health of most Americans aged 20 and over. Dr. Nancy ...

Editas Medicine (NASDAQ:EDIT) is preparing to begin a first-in-human study of EDIT-401, an in vivo CRISPR-edited medicine designed to lower LDL cholesterol in patients with heterozygous familial ...

Novartis just handed the entire Lp(a) drug class a failing grade, and Amgen is taking the worst of the punishment despite ...

Meritus Health is encouraging residents to have their cholesterol checked during National Cholesterol Education Month. High ...

A small gene-editing study significantly reduced LDL cholesterol levels, and the results have stuck a year later.